- Home
- ORGN vs FATE Comparison
ORGN vs FATE Comparison
Compare ORGN & FATE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORGN
- FATE
- Stock Information
- Founded
- ORGN 2008
- FATE 2007
- Country
- ORGN United States
- FATE United States
- Employees
- ORGN N/A
- FATE N/A
- Industry
- ORGN Major Chemicals
- FATE Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ORGN Industrials
- FATE Health Care
- Exchange
- ORGN Nasdaq
- FATE Nasdaq
- Market Cap
- ORGN 131.4M
- FATE 125.7M
- IPO Year
- ORGN N/A
- FATE 2013
- Fundamental
- Price
- ORGN $0.58
- FATE $1.15
- Analyst Decision
- ORGN Strong Buy
- FATE Hold
- Analyst Count
- ORGN 1
- FATE 7
- Target Price
- ORGN $3.00
- FATE $3.58
- AVG Volume (30 Days)
- ORGN 1.7M
- FATE 1.5M
- Earning Date
- ORGN 08-14-2025
- FATE 08-12-2025
- Dividend Yield
- ORGN N/A
- FATE N/A
- EPS Growth
- ORGN N/A
- FATE N/A
- EPS
- ORGN N/A
- FATE N/A
- Revenue
- ORGN $28,667,000.00
- FATE $8,470,000.00
- Revenue This Year
- ORGN $49.18
- FATE N/A
- Revenue Next Year
- ORGN $144.81
- FATE N/A
- P/E Ratio
- ORGN N/A
- FATE N/A
- Revenue Growth
- ORGN N/A
- FATE N/A
- 52 Week Low
- ORGN $0.40
- FATE $0.66
- 52 Week High
- ORGN $1.90
- FATE $4.20
- Technical
- Relative Strength Index (RSI)
- ORGN 41.76
- FATE 53.09
- Support Level
- ORGN $0.49
- FATE $1.06
- Resistance Level
- ORGN $0.95
- FATE $1.18
- Average True Range (ATR)
- ORGN 0.08
- FATE 0.09
- MACD
- ORGN -0.04
- FATE 0.02
- Stochastic Oscillator
- ORGN 19.24
- FATE 72.73
About ORGN Origin Materials Inc.
Origin Materials Inc is a carbon-negative materials company. The platform turns the carbon found in biomass into useful materials, while eliminating the need for fossil resources and capturing carbon in the process. Its products include, PET circular caps and closures, Para-xylene, carbon black, Levulinic acid among others by using materials like food and beverage packaging, clothing, textiles, plastics, car parts, carpeting, tires, adhesives, soil amendments, and fuels.
About FATE Fate Therapeutics Inc.
Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. It is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.